Paper Details

  1. Home
  2. Paper Details

Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration.

Author: AuroraAjay, BartschDirk, ChengLingyun, CorbinPatricia S, El-BradeyMohamed H, FreemanWilliam R, FribergThomas R, RodanantNuttawut, ToyoguchiMitsuko

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

The study investigates predictors of drusen reduction and its relationship to visual acuity after subthreshold infrared laser treatment for nonexudative age-related macular degeneration (ARMD).
Paper Details　
Original Abstract of the Article :
To determine the predictors of drusen reduction in eyes with nonexudative age-related macular degeneration (ARMD) treated with subthreshold infrared (810 nm) diode laser macular grid photocoagulation. Additionally, to determine the relationship of laser-induced drusen reduction and best-corrected vi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0002-9394(02)01691-4

データ提供：米国国立医学図書館（NLM）

Drusen Reduction with Subthreshold Infrared Laser: Exploring a New Approach to Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a common eye condition, and researchers are constantly seeking new ways to treat and manage this disease. It's like searching for a reliable source of water in a vast and arid desert. This study focuses on the use of subthreshold infrared (810 nm) diode laser macular grid photocoagulation in treating nonexudative AMD. The researchers are investigating the effectiveness of this approach in reducing drusen, small deposits that can accumulate in the retina and affect vision.

Subthreshold Infrared Laser: A Potential Tool for Drusen Reduction in AMD

The study findings suggest that subthreshold infrared laser treatment may be effective in reducing drusen in some patients with nonexudative AMD. It's like a desert traveler finding a hidden spring, offering a potential source of relief and improvement. The researchers identified certain predictors of drusen reduction, which can help guide treatment decisions and optimize patient outcomes.

Navigating the Desert of Age-Related Macular Degeneration: Exploring New Treatment Approaches

This research underscores the importance of exploring new treatment options for AMD. It's like a desert explorer, always searching for a new oasis to sustain life and improve well-being. By understanding the potential benefits and limitations of different treatment approaches, we can better manage this common eye condition.

Dr. Camel's Conclusion

This study adds to our understanding of treatment options for AMD, offering a potential new approach to reducing drusen. It's like a camel discovering a new water source in a vast desert, giving hope for better management of this vision-threatening condition.
Date :
  1. Date Completed 2002-11-06
  2. Date Revised 2019-06-27
Further Info :

Pubmed ID

12383815

DOI: Digital Object Identifier

10.1016/s0002-9394(02)01691-4

Related Literature

Article Analysis
・Effective treatment of macular degeneration
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.